SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: pennystock_es, Value_Investor, Zaxzy
Search This Board: 
Last Post: 5/22/2017 11:28:19 AM - Followers: 56 - Board type: Free - Posts Today: 1

 

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NSPR
Current Price
Volume:
Bid Ask Day's Range
PostSubject
#853  Sticky Note NSPR just needs some Great news similar to Value_Investor 05/16/17 07:45:37 PM
#871   Donald Trump is in ISRAEL the country of pennystock_es 05/22/17 11:28:19 AM
#869   Yes, only buying-at-the-ask could get a big block Value_Investor 05/19/17 02:38:24 PM
#868   Looks like selling is drying up. Trying to russ5555 05/19/17 02:18:42 PM
#867   NSPR is great for flippers only since they Rymankoly 05/19/17 11:38:49 AM
#866   During the three month period ended March 31, Rymankoly 05/19/17 10:55:32 AM
#865   You might want to adjust your calculation for Rymankoly 05/19/17 10:35:12 AM
#864   No matter how the shorters and sick MMs Value_Investor 05/19/17 10:03:30 AM
#863   Stories like these cause me to add.. bill_y 05/18/17 02:30:37 PM
#862   NSPR has another Good News just kicked in Value_Investor 05/18/17 09:18:25 AM
#861   Yes, Great news for this hidden gem today! Value_Investor 05/17/17 11:58:47 PM
#860   The news is officially published with the market closed: pennystock_es 05/17/17 04:26:00 PM
#859   Buying NSPR ! Looking Good at this level! stock777777 05/17/17 02:05:08 PM
#858   Grabbed a starter Holdemorfoldem 05/17/17 11:06:52 AM
#857   Very good news ¡¡ pennystock_es 05/17/17 10:27:22 AM
#856   NSPR: Great News finally kicked in today --- Value_Investor 05/17/17 08:56:09 AM
#855   again sales and revenue..nspr is operating at deficit..like bill_y 05/17/17 07:29:45 AM
#853   NSPR just needs some Great news similar to Value_Investor 05/16/17 07:45:37 PM
#852   Good news, but not enough: distribution agreements are Memus 05/16/17 07:07:31 PM
#851   Not true. On May 1 after good news Value_Investor 05/16/17 11:33:00 AM
#850   When does good news ever move this stock porgyrusty 05/16/17 11:23:40 AM
#849   Great News (see the link below) --- Rapid Value_Investor 05/15/17 03:54:49 PM
#848   News $NSPR !! On May 15, 2017, pennystock_es 05/15/17 03:48:05 PM
#847   Today the volume is high, news? pennystock_es 05/15/17 11:51:23 AM
#846   YAW! Total 348,900 shares were shorted as of Value_Investor 05/14/17 08:58:01 PM
#845   Thank you. CIMA7 05/13/17 12:37:55 PM
#844   NSPR is trading at mere 48.67% of its Value_Investor 05/13/17 12:32:50 PM
#843   revenue baby..market acceptance of cguard in areas where bill_y 05/13/17 09:22:06 AM
#842   I'm fairly new to the stock. I can't CIMA7 05/12/17 08:23:18 PM
#841   0.55 x 0.555 ~ 0.559x and no any Value_Investor 05/12/17 08:18:06 PM
#840   Brace for calamity, I bought in @ .56 late Wildbilly 05/12/17 07:39:03 PM
#839   $0.64 x $0.65 in AH! NSPR has finally Value_Investor 05/10/17 11:58:54 PM
#838   I keep accumulating $SNPR, the shorts will have pennystock_es 05/10/17 01:20:06 PM
#837   What happens at $NSPR ? Is trading below pennystock_es 05/10/17 12:12:07 PM
#836   NSPR lots of data out, Wildbilly 05/10/17 08:55:10 AM
#835   InspireMD Provides Business Update for the First Quarter Value_Investor 05/10/17 07:49:09 AM
#834   NSPR: Up 8.8% A-H Good News --- 100% Value_Investor 05/09/17 07:20:02 PM
#833   first quarter financials tomorrow at 8am..eastern time..probably some bill_y 05/09/17 08:12:13 AM
#832   Yes. Once they finish to sign all the Value_Investor 05/08/17 11:29:15 AM
#831   Is it a great News, $NSPR aim to pennystock_es 05/08/17 05:07:11 AM
#830   if you want to talk about a s/p bill_y 05/06/17 05:45:26 PM
#829   Monday may be a good time to buy bill_y 05/06/17 05:42:37 PM
#828   Great Key Europe-Patent News for NSPR last week Value_Investor 05/06/17 12:49:39 PM
#827   meeting on Wednesday to provide first quarter financial bill_y 05/06/17 08:44:08 AM
#826   Great Europe-Patent News for NSPR on 05/01/2017 --- Value_Investor 05/05/17 06:56:51 PM
#825   Also is that the nakedshortreport a scam site Zaxzy 05/05/17 01:21:02 PM
#824   Cool thanks for the info! Zaxzy 05/05/17 01:20:06 PM
#823   Call FINRA by yourself and they will tell Value_Investor 05/05/17 01:17:58 PM
#822   Not to seem like I am arguing with Zaxzy 05/05/17 01:13:23 PM
#821   That is 100% Fake shorting data! The correct Value_Investor 05/05/17 12:39:24 PM
#820   http://nakedshortreport.com/?index=NSPR bill_y 05/05/17 07:42:04 AM
PostSubject